Kariyama Kazuya, Kawanaka Miwa, Nouso Kazuhiro, Wakuta Akiko, Shiota Shohei, Kurisu Akemi, Sugiyama Aya, Akita Tomoyuki, Kumada Takashi, Tanaka Junko
Department of Gastroenterology and Liver Disease Center Okayama City Hospital Okayama City Okayama Japan.
Department of General Internal Medicine 2 General Medical Center, Kawasaki Medical School Okayama City Okayama Japan.
JGH Open. 2024 Jul 25;8(7):e70010. doi: 10.1002/jgh3.70010. eCollection 2024 Jul.
We conducted a study using the Fibrosis-3 (FIB-3) index, which is the established age-independent index of fibrosis in nonviral liver disease and addresses the limitations of the FIB-4 index in older age group, to assess the liver fibrosis risk among diverse demographic groups in the general population.
We analyzed 31 327 individuals who underwent health examinations between 2013 and 2020 and investigated the distribution of the FIB-3 index by age group. In addition, we examined the age distribution of the FIB-3 index stratified by background factors, such as sex, body mass index (BMI), alcohol consumption habits, and the presence or absence of fatty liver.
In terms of age-specific distribution, the FIB-3 index remained below 1.5 in >90% of cases until the age of 50 years but exceeded 1.5 beyond the age of 50 years, in approximately 30% among those aged 70 years. Notably, the FIB-3 index above 31 years old was significantly higher in men than in women. Among the different BMI categories, individuals with BMI < 18.5 exhibited the highest prevalence of fibrosis. Habitual drinkers had a higher proportion with FIB-3. index ≥1.5, and some had FIB-3 index ≥2.5, raising the suspicion of advanced hepatic fibrosis. No distinct association was identified between the FIB-3 index and the presence of fatty liver.
The FIB-3 index was useful for identifying cases of advancing hepatic fibrosis in a health checkup population. Liver fibrosis progresses with age in the general population, especially among men, those with low BMI, and habitual drinkers.
我们使用纤维化-3(FIB-3)指数进行了一项研究,该指数是已确立的非病毒性肝病中与年龄无关的纤维化指数,解决了FIB-4指数在老年人群中的局限性,以评估普通人群中不同人口统计学群体的肝纤维化风险。
我们分析了2013年至2020年间接受健康检查的31327人,并按年龄组调查了FIB-3指数的分布。此外,我们还按性别、体重指数(BMI)、饮酒习惯和是否存在脂肪肝等背景因素对FIB-3指数的年龄分布进行了研究。
就年龄特异性分布而言,在50岁之前,超过90%的病例中FIB-3指数低于1.5,但在50岁之后超过1.5,在70岁人群中约为30%。值得注意的是,31岁以上男性的FIB-3指数显著高于女性。在不同的BMI类别中,BMI<18.5的个体纤维化患病率最高。习惯性饮酒者中FIB-3指数≥1.5的比例较高,部分人FIB-3指数≥2.5,这引发了对晚期肝纤维化的怀疑。未发现FIB-3指数与脂肪肝的存在之间存在明显关联。
FIB-3指数有助于在健康体检人群中识别肝纤维化进展病例。在普通人群中,肝纤维化随年龄增长而进展,尤其是男性、BMI较低者和习惯性饮酒者。